Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether KAI-1678 is effective in the treatment of postherpetic neuralgia pain
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
KAI Pharmaceuticals
Collaborators
NCT06290661 · Postherpetic Neuralgia, Peripheral Neuropathic Pain, and more
NCT07000409 · Postherpetic Neuralgia, Chronic Pain, and more
NCT06896994 · Postherpetic Neuralgia
NCT06232486 · Postherpetic Neuralgia
NCT06225960 · Postherpetic Neuralgia
Sydney, New South Wales
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions